Now that is the government at work, concerned only about your health and well-being.
WASHINGTON — A former Food and Drug Administration scientist said Tuesday his job was eliminated after he raised concerns about the risks of radiation exposure from high-grade medical scanning.
Dr. Julian Nicholas told an audience of imaging specialists that he and other FDA staffers “were pressured to change their scientific opinion,” by managers in the agency’s medical device division.
Nicholas, now a physician at the Scripps Clinic in San Diego, said he and eight other staffers raised their concerns with the division’s top director Dr. Jeffrey Shuren last September.
“Scientific and regulatory review process for medical devices was being distorted by managers who were not following the laws,” Nicholas said. A month later Nicholas’ position was “terminated,” he said.
The allegations about suppression of scientific dissent within FDA are not the first, and come at an inopportune time for the agency.
Tuesday’s meeting was designed to kick off FDA’s campaign to reduce radiation exposure from medical scanning. The agency is seeking input from physicians and manufacturers on additional safety controls and training to improve CT scanners and other medical imaging devices.
Hundreds of studies have linked certain types of radiation, including the type used in medical imaging, to cancer that can surface decades later.
FDA medical reviewer Dr. Robert Smith, a colleague of Nicholas who also presented at Tuesday’s public meeting, said he hoped the FDA would learn a lesson from Nicholas’ testimony.
“Science must not be ignored, suppressed or distorted as that endangers the public,” Smith told the audience.
Agency spokesman Dick Thompson said in a statement the FDA’s inspector general looked into Nicholas’ allegations of retaliation against agency scientists and did not pursue further action or investigation. The agency’s policies do not allow staffers to be penalized for expressing scientific views, he added.
“It is not uncommon for scientists, both internal and external to the agency, to disagree on the safety and effectiveness of products under review or on the steps needed to achieve public health goals,” said the FDA statement.
Nicholas, an Oxford University-trained intestinal specialist, raised specific concerns about the safety and effectiveness of CT screening for colon cancer.
CT scans provide detailed, three-dimensional images of the body, but at a cost: one CT chest scan carries as much radiation as nearly 400 chest X-rays, according to the FDA.
As a reviewer of medical device applications, Nicholas repeatedly rejected a manufacturers’ request to market a CT scanner specifically for colon cancer screening. Nicholas said he is legally barred from naming the manufacturer or discussing the details of its application.
In a June 2009 letter to senior managers, Nicholas stressed that patients should be warned of the radiation risks of CT scanning.
“I hope you understand that the failure to include a warning on the label will mean that patients will undoubtedly develop abdominal cancer and leukemia,” Nicholas wrote “It may not happen tomorrow, but yes, sadly it will happen.”
Nicholas said he was ridiculed by agency managers for “raising the bugaboo of radiation.”
Medical experts are somewhat divided over the usefulness of the so-called virtual colonoscopy, which was designed as a less-invasive alternative to colonoscopy.
The American Cancer Society and the American College of Radiology endorse the procedure for its potential to boost screening for colon cancer, the country’s second leading cancer killer.
But some insurers and the government’s own Medicare program refuse to pay for the procedure, questioning its effectiveness and the rationale of exposing healthy patients to radiation.
Supporters of the procedure say that virtual colonoscopies use low levels of radiation that don’t threaten older patients who get colonoscopies. Radiation exposure that causes cancer accumulates over a lifetime, making younger people the most at-risk population for screening.
“When we look at virtual colonoscopy, the benefits of detecting polyps far outweigh the theoretical risk the low amounts of radiation would have on people of that age,” said Dr. Michael Macari of New York University’s Langone Medical Center.
CT scans became popular because they offer a quick, relatively cheap way to get an almost surgical view of the body. Doctors are free to use them as they choose, but FDA approval for specific indications allows companies to tout those uses in marketing materials.
The average American’s radiation exposure has nearly doubled in the last three decades, largely due to CT tests, according to the FDA.
The FDA announced an effort to improve scanning safety after three California hospitals reported hundreds of acute radiation overdoses last year, with many patients reporting lost hair and skin redness.
By MATTHEW PERRONE (AP)
Mar 30, 2010